ALPG

ALPG

ALPG 詳細

Molecule Name
Alkaline phosphatase
分子の別称
ALPG,GCAP,ALP-1,ALPPL2,PLAP-like,ALPPL,Alkaline phosphatase, germ cell type
Drug Development Progress
治験薬の数3
市販薬剤の数1
研究&開発段階Approved
ターゲットの別称
Alkaline Phosphatase
バックグランド
ALPPL2 is specifically highly expressed in naïve pluripotent stem cells. Moreover, in naïve state somatic cell reprogramming, naïve-primed transformation and other systems, the use of the ALPPL2 promoter-driven fluorescent reporter system can specifically indicate the establishment or withdrawal of naïve state pluripotency, thereby identifying ALPPL2 as naïve state pluripotent. specific cell surface markers. Some studies have found that knockout of ALPPL2 can specifically affect the establishment, stability and maintenance of naïve state pluripotency, proving that ALPPL2 protein is a functional naïve state surface molecular marker.

ALPG 製品リスト

Species
  • Human(2)
  • Mouse(1)
Tag
  • His Tag(2)
  • His Tag & Avi Tag(1)
Host
  • HEK293(3)
Conjugate
  • Unconjugated(2)
  • Biotin-labeled(1)
Grade
  • RUO(3)
Low Endotoxin
  • Yes(1)
  • No(2)
MoleculeCat. No.Product Name種HostStructurePurityActivitySize&Price
ALPG
Human ALPG / ALPPL2 Protein, His Tag, low endotoxin (active enzyme, MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISAEnzyme

$470.00

100ug
ALPG
Avitag
ALG-H52E1
Biotinylated Human ALPG / ALPPL2 Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
ALPG
Mouse ALPG / ALPPL2 Protein, His Tag (active enzyme, MALS verified)
Mouse
HEK293
MALSSDS-PAGE
Enzyme

$410.00

100ug
You Have Viewed 1-3 Of 3 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity

抗体購入プラットフォーム

プロジェクトステージタイプ由来疾患領域適応症
ALPP/ALPPL2 mAb - 01PCCMonoclonalHumanized MouseSolid TumorEndometrial cancer,Ovarian cancer
プロジェクト
ALPP/ALPPL2 mAb - 01
ステージ
PCC
タイプ
Monoclonal
由来
Humanized Mouse
疾患領域
Solid Tumor
適応症
Endometrial cancer,Ovarian cancer
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
ALXN-1850ALXN-1850Phase 3 ClinicalAlexion Pharmaceuticals Inc
Hypophosphatasia
詳細
Amifostine for nasoduodenal delivery (Xerient Pharma)XER-001Phase 2 ClinicalXerient Pharma
Pancreatic Neoplasms
詳細
placenta-derived protein (Zoltan)PALPClinicalZoltan Laboratories
Cachexia; Diabetes Mellitus; Obesity
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
AmifostineWR-2721C; NSC-296961; YM-08310; S-8744; SAPEP; WR-2721ApprovedMedimmune LlcEthyol, 天地达, 安福定Mainland ChinaCytoprotective adjuvantChina Grand Automotive Services Group Co Ltd1995-12-08
Acute Radiation Syndrome; Bone Marrow Diseases; Breast Neoplasms; Carcinoma; Cytoprotective adjuvant; Fanconi Anemia; Gestational Trophoblastic Disease; Head and Neck Neoplasms; Hodgkin Disease; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Mucositis; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Nasopharyngeal Neoplasms; Neurotoxicity Syndromes; Neutropenia; Ovarian Neoplasms; Peripheral Nervous System Diseases; Prostatic Neoplasms; Salivary Gland Diseases; Sarcoma; Solid tumours; Trigeminal Neuralgia
詳細
Customer Reviews